MP Healthcare Venture Management
Boston-based life science venture capital firm that collaborates with healthcare entrepreneurs to develop novel technologies and therapeutics. The firm provides capital and supports portfolio companies through strategic guidance, industry connections and facilitation of corporate collaborations.
Industries
Nr. of Employees
small (1-50)
MP Healthcare Venture Management
Boston, Massachusetts, United States, North America
Portfolio
MPH described as an early investor whose support was transformative in company genesis.
#RNA biology / therapeutics
Multiple corporate collaborations and licensing options reported (Merck, Boehringer Ingelheim, AbbVie, Bristol-Myers Squibb); site references formation of asset-centric vehicles (F-star Alpha/Beta) and large Series A financing.
#Biologics / bispecific antibodies / immuno-oncology
Founding team cites leveraging MPH's network and expertise; MPH was an early investor.
#Biotechnology / therapeutics
Developing oral small-molecule degraders of extracellular proteins; site lists completion of a $12M seed financing.
#Small-molecule therapeutics / protein degraders
Site references multiple collaborations and license agreements involving Covagen.
#Biologics / bispecific fynomabs
Site references completed fundraising and adoption of a program by Amed.
#Gene editing / therapeutics (implied by name and site context)
MPH described as an early investor whose support was transformative in company genesis.
#RNA biology / therapeutics
Multiple corporate collaborations and licensing options reported (Merck, Boehringer Ingelheim, AbbVie, Bristol-Myers Squibb); site references formation of asset-centric vehicles (F-star Alpha/Beta) and large Series A financing.
#Biologics / bispecific antibodies / immuno-oncology
Founding team cites leveraging MPH's network and expertise; MPH was an early investor.
#Biotechnology / therapeutics
Developing oral small-molecule degraders of extracellular proteins; site lists completion of a $12M seed financing.
#Small-molecule therapeutics / protein degraders
Site references multiple collaborations and license agreements involving Covagen.
#Biologics / bispecific fynomabs
Site references completed fundraising and adoption of a program by Amed.
#Gene editing / therapeutics (implied by name and site context)